The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
Anna Secher(Novo Nordisk (Denmark)), Lotte Bjerre Knudsen(Novo Nordisk (Denmark))
Cited by 913
Related Papers
The Discovery and Development of Liraglutide and Semaglutide
|Frontiers in Endocrinology|2019|890
Semaglutide lowers body weight in rodents via distributed neural pathways
|JCI Insight|2020|664
Different domains of the glucagon and glucagon‐like peptide‐1 receptors provide the critical determinants of ligand selectivity
|British Journal of Pharmacology|2003|132
Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products–induced inflammation
|Kidney International|2023|121
Three Distinct Epitopes on the Extracellular Face of the Glucagon Receptor Determine Specificity for the Glucagon Amino Terminus
|Journal of Biological Chemistry|2003|68